Sleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study

IF 1 Q4 CLINICAL NEUROLOGY
Y. Hacımusalar, Ozgul Karaaslan, E. Mısır, O. Amuk, Goknur Hacimusalar
{"title":"Sleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study","authors":"Y. Hacımusalar, Ozgul Karaaslan, E. Mısır, O. Amuk, Goknur Hacimusalar","doi":"10.5935/1984-0063.20210036","DOIUrl":null,"url":null,"abstract":"ABSTRACT Objective: Bipolar disorder (BD) and schizophrenia are chronic psychiatric disorders in which sleep disorders are commonly seen. In mental disorders, residual symptoms may persist even if symptoms are greatly reduced overall. The aim of this study was to compare the sleep quality of schizophrenia and BD patients in remission with that of healthy controls. Methods: Forty-three patients with schizophrenia, 46 BD patients in remission for at least 3 months, and 51 healthy controls were included the study. The Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Young Mania Rating Scale (YMRS) and Pittsburgh Sleep Quality Index (PSQI) were administered to all participants and the Positive and Negative Syndrome Scale (PANSS) was administered to patients with schizophrenia. Results: Poor sleep quality was more frequent in the patient groups than the control group ( p =0.009). PSQI score was positively correlated with duration of disease ( r =0.236; p =0.026), number of cigarettes smoked per day ( r =0.430; p <0.001), body mass index ( r =0.189; p =0.025), and negatively correlated with duration of remission ( r =-0.224; p =0.0359). Conclusion: Schizophrenia and BD patients in remission had worse sleep quality than a control group. Sleep quality was worst in the patients with schizophrenia. The severity of sleep disorder symptoms was positively associated with disease duration and negatively associated with duration of remission. Schizophrenia and BD patients should be carefully evaluated for symptoms of sleep disorders even when they are in clinical remission and should be offered additional treatment for sleep disorder symptoms when necessary.","PeriodicalId":21848,"journal":{"name":"Sleep Science","volume":"1053 1","pages":"47 - 54"},"PeriodicalIF":1.0000,"publicationDate":"2021-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/1984-0063.20210036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

ABSTRACT Objective: Bipolar disorder (BD) and schizophrenia are chronic psychiatric disorders in which sleep disorders are commonly seen. In mental disorders, residual symptoms may persist even if symptoms are greatly reduced overall. The aim of this study was to compare the sleep quality of schizophrenia and BD patients in remission with that of healthy controls. Methods: Forty-three patients with schizophrenia, 46 BD patients in remission for at least 3 months, and 51 healthy controls were included the study. The Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Young Mania Rating Scale (YMRS) and Pittsburgh Sleep Quality Index (PSQI) were administered to all participants and the Positive and Negative Syndrome Scale (PANSS) was administered to patients with schizophrenia. Results: Poor sleep quality was more frequent in the patient groups than the control group ( p =0.009). PSQI score was positively correlated with duration of disease ( r =0.236; p =0.026), number of cigarettes smoked per day ( r =0.430; p <0.001), body mass index ( r =0.189; p =0.025), and negatively correlated with duration of remission ( r =-0.224; p =0.0359). Conclusion: Schizophrenia and BD patients in remission had worse sleep quality than a control group. Sleep quality was worst in the patients with schizophrenia. The severity of sleep disorder symptoms was positively associated with disease duration and negatively associated with duration of remission. Schizophrenia and BD patients should be carefully evaluated for symptoms of sleep disorders even when they are in clinical remission and should be offered additional treatment for sleep disorder symptoms when necessary.
精神分裂症和双相情感障碍患者的睡眠质量受损在缓解期持续:一项病例对照研究
目的双相情感障碍(BD)和精神分裂症是以睡眠障碍为主的慢性精神疾病。在精神障碍中,即使症状总体上大大减轻,残余症状也可能持续存在。本研究的目的是比较精神分裂症和双相障碍缓解期患者与健康对照者的睡眠质量。方法选取43例精神分裂症患者、46例缓解期3个月以上的双相障碍患者和51例健康对照者作为研究对象。所有受试者均采用贝克焦虑量表(BAI)、贝克抑郁量表(BDI)、青年躁狂症评定量表(YMRS)和匹兹堡睡眠质量指数(PSQI),精神分裂症患者采用阳性和阴性综合征量表(PANSS)。结果患者组睡眠质量差发生率高于对照组(p=0.009)。PSQI评分与病程呈正相关(r=0.236;P =0.026),每天吸烟的数量(r=0.430;P <0.001),体重指数(r=0.189;P =0.025),且与缓解持续时间呈负相关(r=-0.224;p = 0.0359)。结论精神分裂症和双相障碍缓解期患者睡眠质量较对照组差。精神分裂症患者的睡眠质量最差。睡眠障碍症状的严重程度与疾病持续时间呈正相关,与缓解持续时间负相关。精神分裂症和双相障碍患者应仔细评估睡眠障碍症状,即使他们处于临床缓解期,也应在必要时为睡眠障碍症状提供额外治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sleep Science
Sleep Science CLINICAL NEUROLOGY-
CiteScore
2.50
自引率
12.50%
发文量
124
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信